In 2001, our group showed that hyperferritinemia with normal transferrin saturation was a hallmark of a glucose/lipid metabolism disorder and, when associated with multiple metabolic abnormalities and iron overload, identified patients at risk for NASH. This evidence concerns the gene TF and isolated hyperferritinemia.